Skip to the page

Data / Drug companies / QPharma, Inc.

QPharma, Inc.: 120 products in the FDA NDC directory, labeler code 42708

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

QPharma, Inc. (labeler code 42708) lists 120 products in the FDA National Drug Code Directory, covering 48 finished drugs by generic name. By type: 120 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on December 6, 2025.

The request: Watch QPharma, Inc. (FDA labeler code 42708): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
42708
Products in commercial distribution
120
Packages
121
Finished drugs by generic name
48
Prescription products
120
Over the counter products
0
Started marketing in the last 12 months
1
Products with a marketing end date set
1
Earliest marketing start
January 12, 1973
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)11898.3%
Other unapproved drugs10.8%
Authorized generics (NDA)10.8%

Products by type

TypeProductsShare
Prescription drugs120100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet, film coated4739.2%
Tablet4335.8%
Capsule1613.3%
Capsule, delayed release54.2%
Tablet, delayed release32.5%
Capsule, extended release21.7%
Tablet, film coated, extended release10.8%
Tablet, coated10.8%
Capsule, gelatin coated10.8%
Tablet, extended release10.8%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Amlodipine Besylate42708-204TabletGeneric drugs (ANDA)December 6, 2025
Metformin hydrochloride42708-203Tablet, film coatedGeneric drugs (ANDA)August 25, 2025
Metformin hydrochloride42708-202Tablet, film coatedGeneric drugs (ANDA)August 25, 2025
Fluoxetine42708-200CapsuleGeneric drugs (ANDA)July 11, 2025
Metoprolol tartrate42708-198TabletGeneric drugs (ANDA)January 17, 2024
Meclizine Hydrochloride42708-189TabletGeneric drugs (ANDA)April 22, 2022
Prednisone42708-195TabletGeneric drugs (ANDA)March 28, 2022
NITROFURANTOIN (monohydrate/macrocrystals)42708-184CapsuleGeneric drugs (ANDA)February 22, 2022
Prednisone42708-186TabletGeneric drugs (ANDA)September 1, 2021
Prednisone42708-166TabletGeneric drugs (ANDA)September 1, 2021
Lisinopril42708-176TabletGeneric drugs (ANDA)June 1, 2021
Cyproheptadine hydrochloride42708-187TabletGeneric drugs (ANDA)February 24, 2021
Omeprazole42708-170Capsule, delayed releaseGeneric drugs (ANDA)July 1, 2019
Prednisone42708-136TabletGeneric drugs (ANDA)March 7, 2019
Atorvastatin Calcium42708-144Tablet, film coatedGeneric drugs (ANDA)December 23, 2018
Atorvastatin Calcium42708-141Tablet, film coatedGeneric drugs (ANDA)December 23, 2018
Benzonatate42708-171CapsuleGeneric drugs (ANDA)December 21, 2018
Losartan Potassium and Hydrochlorothiazide42708-193Tablet, film coatedGeneric drugs (ANDA)February 15, 2018
Cyclobenzaprine hydrochloride42708-197Tablet, film coatedGeneric drugs (ANDA)May 31, 2017
Lisinopril42708-165TabletGeneric drugs (ANDA)May 12, 2017
Lisinopril42708-154TabletGeneric drugs (ANDA)May 12, 2017
Atorvastatin Calcium42708-005Tablet, film coatedGeneric drugs (ANDA)May 4, 2017
Atorvastatin Calcium42708-004Tablet, film coatedGeneric drugs (ANDA)May 4, 2017
Atorvastatin Calcium42708-003Tablet, film coatedGeneric drugs (ANDA)May 4, 2017
Benzonatate42708-082CapsuleGeneric drugs (ANDA)March 22, 2017

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.